Artivion AORT
NYSE AORT
$28.07 -0.75 (-2.60%)
At close: Aug 20, 2026 · 1:16 PM UTC

Artivion (AORT) Liabilities and Shareholders Equity (2010 - 2026)

Artivion's (AORT) quarterly Liabilities and Shareholders Equity came in at $883.2 million in Q1 2026, up 11.63% YoY from $791.2 million in Q1 2025, and little changed on a QoQ basis from $884.8 million in Q4 2025.

Artivion (AORT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Artivion (AORT) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $883.2 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 11.63% year-over-year to $883.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 billion (up 9.17% YoY) and the FY2025 annual result came in at $884.8 million, up 12.13% from the prior year.
  • Liabilities and Shareholders Equity held at $883.2 million in Q1 2026, from $884.8 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $884.8 million in Q4 2025 to a low of $742.7 million in Q3 2022.
  • A 5-year average of $798.5 million and a median of $789.1 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slipped 9.27% — and 2025, when it climbed 12.13%.
  • Tracing AORT's Liabilities and Shareholders Equity over 5 years: stood at $762.8 million in 2022, then rose by 3.88% to $792.4 million in 2023, then slipped by 0.42% to $789.1 million in 2024, then rose by 12.13% to $884.8 million in 2025, then retreated by 0.19% to $883.2 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $883.2 million (Q1 2026), $884.8 million (Q4 2025), and $857.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn 109.22 Bn
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 31.04 Bn
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn 10.74 Bn
10 Artivion 1.36 Bn 1.29 Bn 80.52 Mn 1.07 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.07 Bn
Mar 31, 2026 883.16 Mn
Dec 31, 2025 884.80 Mn
Sep 30, 2025 857.66 Mn
Jun 30, 2025 838.39 Mn
Mar 31, 2025 791.16 Mn
Dec 31, 2024 789.10 Mn
Sep 30, 2024 803.14 Mn
Jun 30, 2024 789.54 Mn
Mar 31, 2024 784.01 Mn
Dec 31, 2023 792.40 Mn
Sep 30, 2023 774.79 Mn
Jun 30, 2023 777.86 Mn
Mar 31, 2023 757.07 Mn
Dec 31, 2022 762.80 Mn
Sep 30, 2022 742.73 Mn
Jun 30, 2022 764.86 Mn
Mar 31, 2022 781.86 Mn
Dec 31, 2021 793.05 Mn
Sep 30, 2021 818.65 Mn